Competitive Landscape The Europe Glucagon-Like Peptide-1 Agonists Market is consolidated, with major manufacturers, namely Eli Lilly, Sanofi, Novo Nordisk, AstraZeneca, etc., holding a presence in the region
Signs include difficulty breathing, swelling, or a rash
Zepbound has FDA approval for two main uses: Chronic weight management in adults with obesity or adults who are overweight with one or more obesity-related health conditions, such as high blood pressure, diabetes, or high cholesterol
If you are still in the 2.5-5 mg titration window, KwikPen at $299-$399 is competitive with compounded entry pricing and removes the reconstitution step
Some investigators believe it arises from the retinal anlage, whereas others consider an odontogenic origin